Abstract. The amyloid-␤ peptide (A ␤ ) can mediate cell attachment by binding to ␤ 1 integrins through an arg-his-asp sequence. We show here that the ␣ 5 ␤ 1 integrin, a fibronectin receptor, is an efficient binder of A ␤ , and mediates cell attachment to nonfibrillar A ␤ . Cells engineered to express ␣ 5 ␤ 1 internalized and degraded more added A ␤ 1-40 than did ␣ 5 ␤ 1-negative control cells. Deposition of an insoluble A ␤ 1-40 matrix around the ␣ 5 ␤ 1-expressing cells was reduced, and the cells showed less apoptosis than the control cells. Thus, the ␣ 5 ␤ 1 integrin may protect against A ␤ deposition and toxicity, which is a course of Alzheimer's disease lesions.
I ntegrin -mediated cell adhesion is necessary for the survival of many types of cells, and loss of adhesion causes apoptosis (reviewed in Frisch and Ruoslahti, 1997) . The ␣ 5 ␤ 1 integrin may have a particularly prominent antiapoptotic effect because ␣ 5 ␤ 1 is the only integrin that protects cells from apoptosis in serum-free cultures (Zhang et al., 1995; O'Brien et al., 1996) . ␣ 5 ␤ 1-mediated adhesion upregulates the antiapoptosis protein Bcl-2 (Zhang et al., 1995) , and ␣ 5 ␤ 1 is one of a few integrins that activates the signaling protein Shc (Wary et al., 1996) . These signaling events may partly explain its antiapoptotic effects.
␤ 1 integrins have been shown to mediate cell adhesion to the amyloid beta (A ␤ ) 1 protein, and ␣ 5 ␤ 1 has been proposed to be the integrin responsible for the A ␤ binding (Ghiso et al., 1992) . The amino acid sequence arg-his-asp (RHD) has been pinpointed as the integrin recognition site in A ␤ (Ghiso et al., 1992; Sabo et al., 1995) . This sequence resembles the general integrin recognition sequence RGD present in many extracellular matrix proteins (Ruoslahti, 1996 a ) .
A ␤ is a 39-42 amino acid protein derived from proteolytic cleavage of a larger membrane-spanning glycoprotein, the amyloid precursor protein (APP; Kang et al., 1987) . A ␤ forms fibrillar aggregates that can cause cell death by apoptosis (Loo et al., 1993; Pike et al., 1993; Lorenzo and Yanker, 1994) . Enhanced deposition of A ␤ matrix within the cortex, hippocampus, and vasculature of the brain correlates with neuronal cell death and ultimately dementia in Alzheimer's disease (AD; reviewed by Selkoe, 1994) . Two predominant forms of A ␤ (1-40 and 1-42) exist in AD that differ by two amino acid residues at the hydrophobic COOH terminus, a domain that is required for nucleation-dependent fibril formation (Jarret et al., 1993) . The A ␤ 1-40 form has a slower rate of fibril formation in vitro than the A ␤ 1-42 form (Jarret et al., 1993) .
There is evidence for three mechanisms of A ␤ accumulation: overproduction of A ␤ , production of longer forms of A ␤ (which aggregate more), and impaired clearance of A ␤ . The clearance pathways for fibrillar and soluble A ␤ are incompletely known. Two cell surface receptors are known to bind A ␤ . The scavenger receptor present on glial cells binds specifically to fibrillar A ␤ , and appears to mediate clearance of small fibrillar A ␤ aggregates in vitro (Paresce et al., 1996; Khoury et al., 1996) . The receptor for advanced glycation end products binds both the soluble and fibrillar forms of A ␤ , and may mediate some of the cytotoxic effects of fibrillar A ␤ (Yan et al., 1996) .
Because ␣ 5 ␤ 1 may also be an A ␤ receptor, and because ␣ 5 ␤ 1 and A ␤ have apparently contrasting effects on apoptosis, we sought to determine whether ␣ 5 ␤ 1 is indeed an A ␤ -binding integrin and, if so, what effect it might have on the metabolism of A ␤ and on cell survival. We show here that nonfibrillar A ␤ binds to the ␣ 5 ␤ 1 integrin, and that
Reagents
Amyloid beta 1-40 peptide (A ␤ ) was synthesized as previously described (Nordstedt et al., 1994) . A ␤ was also purchased from a commercial source (Synthetic Amyloid Beta peptide 1-40; Bachem, Torrance, CA). A ␤ 1-40 from both sources was examined for cell adhesion activity. Two out of the three Bachem lots tested showed adhesive activity (lots zn571 and wm365), while lot zn327 was not active. For water-free storage to prevent aggregation of A ␤ into its fibrillar form, the peptide was dissolved and stored in 1,1,1,3,3,3,-hexafluoro-2-propanol (HFIP; Fluka Chemika, NeuUlm, Switerland). Before use, the peptide was lyophilized from HFIP, dissolved in sterile distilled water at 1 mg/ml, and tested immediately. The control peptide, A ␤ 40-1, was purchased from Bachem, solubilized in water at 1 mg/ml, and tested immediately. Fibronectin was purchased from Chemicon International, Inc. (Temecula, CA), and vitronectin was purified as described (Yatohgo et al., 1988) . Purified anti-human ␣ 5 integrin monoclonal antibody (P1D6; Calbiochem-Novabiochem Corp., La Jolla, CA; Wayner et al., 1988) and purified mouse IgG (Sigma Chemical Co.) were used at a concentration of 50 g/ml.
Transfection
The CHO-B2/ ␣ 5 ␤ 1 ϩ , CHO-B2/ ␣ v ␤ 1 ϩ , and IMR-32/ ␣ 5 ␤ 1 ϩ cells were generated by introducing cDNAs coding for the ␣ 5 and ␣ v integrin subunits into ␣ 5 ␤ 1-deficient CHO-B2 and IMR-32 cells (Schreiner et al., 1989; Bauer et al., 1992; Zhang et al., 1993 Zhang et al., , 1995 . Transfectants expressing the integrin were cloned and expanded (Zhang et al., 1993; Zhang et al., 1995) . CHO-B2 and IMR-32 control cells received the empty vector.
Integrin Analysis
Integrin expression of IMR-32 and CHO transfectants was analyzed by FACS using monoclonal antibodies against human ␣ 5 (P1D6), ␣ v (L230), and ␤ 1 (P4C10). FITC-conjugated goat anti-mouse antibody (Sigma Chemical Co.) was used as the secondary antibody. The same integrin antibodies were used to block integrin function in other experiments.
Cell Adhesion to Nonfibrillar A ␤ 1-40
The cell attachment assay and the use of antibodies and peptides as inhibitors of adhesion have been described previously (Zhang et al., 1993; Matter and Laurie, 1994) . Microtiter plates coated overnight at room temperature with nonfibrillar A␤1-40 peptide, control A␤40-1 peptide, or fibronectin were blocked with 1% BSA for 30 min at room temperature, the wells were rinsed once with PBS (pH 7.4), and cells were subsequently added (2 ϫ 10 5 cells/well) in serum-free media and incubated for 60 min (37ЊC). Inhibition studies were performed by preincubating cells with antibody for 30 min (37ЊC; gentle agitation every 10 min), and then cells including antibodies were added to the coated wells. After a 60-min incubation at 37ЊC, plates were gently washed four times with PBS, fixed with 1% glutaraldehyde (Sigma Chemical Co.), PBS-washed once, stained with 0.5% crystal violet, 20% MEOH, washed under running distilled water, solubilized in 0.1 N sodium citrate, 50% ETOH, and read on an ELISA plate reader (Molecular Devices Corp., Sunnyvale, CA) using the 590-nm filter.
Adhesion assays with fibrillar A␤1-40 were performed as above. Before the adhesion assay, soluble A␤1-40 was incubated at 4ЊC for 96 h to allow self-aggregation of A␤1-40 into its fibrillar form (Jarret et al., 1993 
Immunostaining of A␤ Fibrillar Matrix
Cells were plated on four-well Permanox™ plastic slides (Nunc Inc., Naperville, IL) at 50,000 cells/well. 6 h after plating, the media was replaced with media containing A␤1-40 peptide (100 g/ml) and incubated for 72 h at 37ЊC. The cultures were washed with PBS and fixed in PBS containing 3.7% paraformaldehyde and 10 mM sucrose, pH 7.4, for 30 min at room temperature. The cultures were then blocked with 1% BSA/PBS and stained with a polyclonal rabbit anti-human A␤1-40 peptide antibody (Chemicon International, Inc.) for 2 h, followed by goat anti-rabbit FITClabeled IgG (Sigma Chemical Co.) secondary antibody. After antibody treatment, coverslips were mounted with Vectashield mounting medium (Vector Labs., Inc., Burlingame, CA) and analyzed under a fluorescent confocal microscope. 6 Ci/mmol. Insolubilization of A␤ was analyzed using 125 I-labeled A␤1-40 peptide as described previously for fibronectin matrix assembly (McKeownLongo and Mosher, 1985; Morla and Ruoslahti, 1992) . Cells were plated at 10 5 cells/ml (IMR variants) or 0.5 ϫ 10 5 cells/ml (CHO variants) into 24-well tissue culture plates in media containing 10% serum. Media was replaced 6 h after plating with media containing [
Analysis of A␤ in
125 I]A␤1-40 and 10% serum. Cells were cultured for 72 h at 37ЊC. The media was then removed, the wells were washed three times with PBS, and 5ϫ SDS sample buffer (0.5M Tris pH 6.8, glycerol, 10% SDS, 0.5% bromophenol blue) was used to solubilize the [ 125 I]A␤ matrix in each well. For antibody inhibition experiments, cells were plated as above. 6 h after plating, the media was replaced with media containing the appropriate antibody and 10% serum.
125 I-labeled A␤1-40 peptide (2 ng/well) was added to the antibody-containing media and incubated for 72 h at 37ЊC. The cells were then processed as above.
Internalization and Degradation of [

I]Soluble A␤1-40
Internalization of A␤1-40 added to cell layers was measured as described (Duckworth et al., 1972; McDermott and Gibson, 1997) . Subconfluent cells were trypsinized and plated onto 24-well plates. Media was replaced 6 h after plating with [
125 I]A␤1-40 (2 ng/ml). The cells were incubated for 1 h with [
125 I]A␤1-40, the media was removed, cells were washed five times with PBS, and serum-containing media containing no A␤1-40 was added. The cells were cultured for 1 to 12 h at 37ЊC, washed three times with PBS, detached by EDTA, washed twice with PBS, lysed in 100 l of 1% NP40 buffer for 10 min at 4ЊC, and lysate-analyzed for radioactivity.
For TCA precipitations, the cells were cultured for 72 h with [
125 I]A␤1-40 at 37ЊC, washed three times with PBS, detached by EDTA, washed twice with PBS, and lysed in 100 l of 1% NP40 buffer for 10 min at 4ЊC. BSA/ PBS (100 l, 1%) was added to the samples, the samples were vortexed, and 1.6 ml of TCA (12.5% wt/vol) was added with vortexing. The samples were centrifuged at 2,000 rpm for 10 min at 4ЊC, and the supernatant and pellet were collected for radioactive counting.
Secretion of 125 I-Labeled A␤1-40
Subconfluent cells were detached with trypsin, washed once with media, and plated at 10 5 cells/ml in 24-well plates. 6 h after plating, media was replaced with 2 ng/ml of [ 125 I]A␤1-40 in serum-containing media and incubated for 1 h at 37ЊC. The radiolabeled media was removed, and cells were washed five times in PBS before serum-containing media containing no A␤ was added to each well. At designated time points, 100 l of media was collected, and [
125 I] was measured.
Apoptosis and Cell Viability Assays
The apoptotic effect of fibrillar A␤ was determined using the Apoptag Plus In Situ Apoptosis Kit™ (Oncor, Inc., Gaithersburg, MD) that detects the 3Ј-OH region of cleaved DNA. Cells were plated on eight-chamber tissue culture glass slides (Miles Scientific Laboratories, Inc., Naperville, IL), and 6 h after plating the media was replaced with media containing either A␤1-40 peptide (50 g/ml) or A␤40-1 control peptide (50 g/ml) and 10% serum. Cells were cultured for 72 h at 37ЊC, and were then fixed in a solution containing 3.7% paraformaldehyde, 10 mM sucrose in PBS for 30 min at room temperature. Cells were stained following kit protocol, counterstained with propidium iodide/antifade solution (Oncor, Inc.), mounted, and viewed under a confocal microscope.
To measure apoptosis by nuclear fragmentation, cells were plated in wells coated with either 50 g/ml of fibronectin, vitronectin, or A␤1-40 for 72 h in serum-free medium. Attached and floating cells were then collected by centrifugation, washed once with PBS, fixed with 3.7% paraformaldehyde for 10 min at room temperature, and stained with 0.1 g of 4Ј, 6-diamidino-2-phenylindole (DAPI) per ml in PBS. The stained cells were washed three times with PBS and mounted onto slides for analysis under a fluorescence microscope (Zhang et al., 1995) .
Cell viability was assessed in several assays. The ability of cells to take up acridine orange/ethidium bromide was measured as described (Cotter and Martin, 1996) . In brief, the assay was performed in 96-well tissue culture plates containing 100 l media/well. Cells were plated in media containing 10% serum. 6 h after plating, the media was replaced with media containing various concentrations of the test reagents and 10% serum. The plates were incubated for 72 h at 37ЊC. At the 72-h time point, cells were trypsinized and resuspended in PBS at 0.5 ϫ 10 6 cells/ml. 1 l from a solution of acridine orange (100 g/ml) and ethidium bromide (100 g/ml) was added to a 25-l cell suspension, incubated for 2 min at room temperature, and examined under 40ϫ magnification using a Zeiss Fluorescence microscope.
Cells cultured in microtiter wells were pulsed with 25 l of a 2.5 mg/ml MTT stock in PBS and incubated for 4 h. Then 100 l of a solution containing 10% SDS, 0.01 N HCl was added, and the plates were incubated overnight (Tada et al., 1986) . Absorption was read on a Vmax Microplate Reader™ (Molecular Devices Corp., Sunnyvale, CA) using a reference wavelenth of 650 nm and a test wavelength of 590 nm. Test reagents were added to media alone in order to provide a blank.
To measure lactate dehydrogenase (LDH) release from cells, the colorimetric Cytotox 96-LDH-Release Assay™ (Promega Corp., Madison, WI) was performed according to the instructions of the manufacturer. 
Results
The Integrin ␣5␤1 Mediates Cell Adhesion to Nonfibrillar A␤1-40
The RHD sequence in A␤ resembles the integrin recognition sequence RGD, and has been implicated in cell adhesion to A␤ via one or more of the ␤1 integrins (Ghiso et al., 1992; Sabo et al., 1995) . We set out to determine which of the RGD-binding integrins bind to A␤. A CHO cell line deficient in ␣5 integrin subunit expression (CHO-B2) was transfected with cDNA encoding human ␣5, ␣v, or vector alone, and was examined for its ability to adhere to a surface coated with A␤1-40. Each of the integrin transfectants adhered to A␤ in a dose-dependent manner, but cells that received the vector alone attached to A␤ within the BSA background range (Fig. 1 A) . CHO-B2/␣5␤1 ϩ cells adhered strongly to A␤, and CHO-B2/␣v␤1 ϩ cells were moderately adhesive, whereas the control cells CHO-B2/c did not adhere above BSA background levels. FACS analysis indicated that CHO-B2/␣5␤1 ϩ and CHO-B2/␣v␤1 ϩ cell transfectants were similar in their expression of the transfected integrin (Fig. 2, D and E) . A control peptide in which the A␤ sequence is inverted (A␤40-1) did not have adhesive activity with any of the cell types tested (Fig. 1 B) . In addition, integrin transfectants adhered only to soluble nonfibrillar A␤1-40, and not to fibrillar A␤1-40 (Fig. 1 B) .
Plates were coated with equal amounts of soluble and fibrillar A␤1-40 as measured by [ 125 I]A␤1-40. The ␣5␤1-mediated cell adhesion to soluble A␤1-40 was inhibitable by the integrin-binding peptide GRGDSP, and by a function-blocking anti-␣5 integrin monoclonal antibody (P1D6; Fig. 1 C) , but not by the control peptide GRGESP or a monoclonal antibody to ␣v (Fig. 1 C) . The ␣v␤3 integrin, which also binds to RGD, does not mediate adhesion to A␤ because ␣v␤3-expressing IMR-90 cells did not adhere to A␤ when the ␣5␤1 and ␣v␤1 integrins were blocked with anti-␣5 and anti-␤1 monoclonal antibodies (data not shown).
We also tested the ␣5-negative human neuroblastoma cell line IMR-32 (Neill et al., 1994) for A␤ attachment with (IMR-32/␣5␤1 ϩ ) and without (IMR-32/c) ␣5 transfection (Fig. 2 A) . Three separate clones were obtained that expressed human ␣5␤1 on their surface as detected by FACS analysis (Fig. 2, A-C) . Each ␣5␤1-expressing clone adhered to coated A␤1-40 in a dose-dependent manner (Fig. 3 A) , and cell adhesion was inhibitable by an anti-␣5 antibody (data not shown). The control-transfected IMR-32 cells (Fig. 2, A-C) attached poorly to this substrate (Fig. 3  A) . Both the transfected and control cells attached well to vitronectin (data not shown), whereas the control peptide A␤40-1 and fibrillar A␤1-40 did not promote adhesion above BSA background levels for any of the IMR-32 cell lines (Fig. 3 B) .
␣5␤1 Reduces the Formation of an Insoluble A␤ Fibrillar Extracellular Matrix
An increase of insoluble A␤ fibrillar matrix is one hallmark of AD (Glenner and Wong, 1984; Masters et al., 1985) . As shown above, the ␣5␤1 integrin bound to coated A␤ with the highest avidity among the integrins we tested. Therefore, we asked whether ␣5␤1 would affect the formation of an A␤ fibrillar matrix. Exogenous A␤1-40 added to cell cultures formed a matrix around the cells that was detectable by immunostaining with anti-A␤ antibodies. There was a substantial decrease in the formation of matrix from added A␤ in cultures of the ␣5␤1-expressing IMR-32 cell lines compared with the control lines (Fig.  4, A-D) . Moreover, the matrix in the ␣5␤1 ϩ cell cultures appeared to be cell-associated, whereas in the ␣5␤1 Ϫ cell cultures it appeared to be largely independent of the cells.
To study quantitatively the formation of the A␤ matrix, the various IMR-32 lines were incubated with 125 I-labeled A␤ for 72 h, and the amount of radiolabeled A␤ that had become soluble in detergent was measured. The IMR-32 clones expressing ␣5␤1 deposited fivefold less insoluble A␤ radioactivity than the control cells. Moreover, the P1D6 anti-␣5 antibody returned A␤ matrix formation in the ␣5␤1-expressing IMR-32 cultures to the level in the parental control cells (Fig. 5 A) . A control antibody had no effect. CHO cells expressing ␣5␤1 also had less A␤ matrix than their control-transfected counterpart cells as judged from the insolubility of [ 125 I]A␤; the difference was fourfold (Fig. 5 B) . Adding the anti-␣5 antibody canceled the ␣5␤1 effect, but a control antibody did not. The insolubility of A␤ remained the same in the CHO control cell cultures regardless of the antibody added. These results indicate that cell expression of ␣5␤1 reduces A␤ matrix deposition threefold relative to the control cells. Because iodinated A␤ forms fibrils less readily than unlabeled A␤1-40 (Bush et al., 1994) , it was not possible to use the [ 125 I]A␤ to quantitate the proportion of the added A␤1-40 that becomes insolubilized.
Soluble A␤1-40 is Taken Up By Cells and Partially Degraded Via an ␣5␤1-Mediated Pathway
Possible reasons for the ␣5␤1-mediated reduction of A␤ matrix include internalization of soluble A␤1-40, degradation of the peptide, or both. Neuronal cells have been shown to internalize A␤, but the mechanism for this internalization is only incompletely known (Ida et al., 1996 , Hammad et al., 1997 . To investigate the possibility that binding ␣5␤1 to soluble A␤ initiates cellular uptake of A␤, we examined the processing of 125 I-labeled A␤1-40 by ␣5␤1 ϩ and ␣5␤1 Ϫ cells. Initially, CHO-B2/c control cells and transfectants were incubated for 1 h with [
125 I]A␤1-40, and were then examined for cell-associated radioactivity. The ␣5␤1-expressing CHO-B2 cells contained twofold more radioactivity at 1 and 12 h than the control CHO-B2/c cells (Fig. 6 A) .
Cell cultures were then incubated with 125 I-labeled A␤ over a 72-h period to determine whether the [ 125 I]A␤ taken up by the cells was degraded. ␣5␤1-expressing IMR-32 cells contained twofold more radioactivity after the 72-h in- cubation than ␣5␤1-negative IMR-32 cells (Fig. 6 B) . Part of the radioactivity was soluble in TCA, indicating that A␤ had been degraded. CHO cells internalized and degraded soluble A␤ in a similar manner, with ␣5␤1-expressing cells containing eightfold more TCA-soluble radioactivity than ␣5␤1-negative cells (Fig. 6 C) . The CHO cells expressing ␣5␤1 bound 10% of the added A␤, whereas the control cells bound only 0.4%. Moreover, 90% of the cell-associated A␤ was degraded in the CHO-␣5␤1 expressers. The higher expression levels of ␣5␤1 on the CHO transfectants (Fig. 2, D and E) may explain why these cells bound and internalized more radiolabeled A␤ than the IMR-32 transfectants.
We next examined whether A␤ was released into the culture medium. The release of radioactivity into cell culture media was monitored over a 72-h period that followed a 1-h incubation with 125 I-labeled A␤1-40. The media of ␣5␤1-expressing IMR-32 and CHO cells contained twofold more radioactivity than the corresponding control cell media (Fig. 6, D and E) . These results point to an ␣5␤1-dependent pathway that internalizes and degrades A␤.
␣5␤1 Protects Cells Against A␤ Induced Apoptosis
Having established an ␣5␤1-dependent mechanism for the inhibition of A␤ matrix deposition, we examined whether the reduction of the A␤ matrix would promote neuronal cell survival in cultures treated with A␤. IMR-32 cell lines cultured with exogenous soluble A␤1-40 underwent apoptosis in the absence of ␣5␤1 (Fig. 7, A and B) , but three ␣5␤1-expressing lines did not (two are shown in Fig. 7, C and D). The control peptide A␤40-1 caused no apoptosis in the control (Fig. 7, E and F) or ␣5␤1-expressing cells (not shown). Analysis of acridine orange/ethidium bromide uptake revealed three times more apoptosis in the control cells than in the IMR-32 ␣5␤1-expressers (Fig. 8) .
We also assessed the A␤ effect by using the MTT assay, which measures cell viability by detecting the ability of a mitochondrial enzyme to reduce its substrate. A␤-treated IMR-32 control cells lost their ability to reduce MTT in a manner that was dependent on the dose of A␤, whereas A␤ had almost no effect on the ␣5␤1-expressing cell lines (Fig. 9 A) . The control peptide A␤40-1 had no effect on MTT reduction in any of the cell types, even at the highest test concentration (Fig. 9 B) . To examine further the cytotoxicity of A␤1-40, we used an assay that measures the release of LDH upon cell lysis (Behl et al., 1994) . A threefold increase in LDH levels relative to controls was seen in the ␣5␤1 Ϫ IMR-32 cells cultured in the presence of A␤1-40, whereas A␤1-40 had no effect on the LDH levels of the ␣5␤1 ϩ cells (Fig. 10 A) . These results indicate that ␣5␤1-mediated A␤ binding protects the IMR-32 cells from the cytotoxicity of aggregated A␤, presumably by inhibiting its aggregation into fibrils. No apoptosis was caused by A␤ in any of the CHO cell lines, as examined by TUNEL staining, the MTT assay, and the LDH assay, indicating that these cells are resistant to the cytotoxic effects of an A␤ matrix.
We previously demonstrated that cell attachment through ␣5␤1 protects CHO cells from apoptosis when cultured in a serum-free environment (Zhang et al., 1995) . Therefore, we examined whether ligation of ␣5␤1 to coated A␤1-40 125 I] to A␤ matrix relative to control CHO cells. The experimental procedure was the same as in A. The P1D6 antibody reversed the ␣5␤1-dependent matrix reduction, whereas the control mouse IgG had no effect. Experiments in A and B were repeated at least four times, and representative results are shown. Values represent the mean Ϯ SD; n ϭ 3.
would protect ␣5␤1-expressing CHO cells from apoptosis in serum-free cultures. CHO-B2/␣5␤1 ϩ cells were plated on either fibronectin, vitronectin, or A␤-coated dishes and examined for survival 96 h after serum withdrawal. CHO-B2/␣5␤1 ϩ cells survived on A␤ and fibronectin, whereas cells plated on vitronectin underwent apoptosis (Fig. 10  B) . These results indicate that ␣5␤1 can also protect cells from apoptosis by mediating cell attachment to coated A␤.
Discussion
We report that the ␣5␤1 integrin mediates cell adhesion to A␤ and promotes internalization and degradation of A␤. This ␣5␤1-A␤ interaction correlates with both an increase in the clearance of soluble A␤, a reduction in the formation of an insoluble A␤ fibrillar matrix, and a decrease of the toxicity of A␤ to cells. This study provides one mechanism for regulating A␤ accumulation.
Our data, showing that A␤ binds to ␣5␤1, and to a lesser extent ␣v␤1, is in agreement with previous reports that A␤ mediates cell attachment, and that the RHD sequence in it serves as an integrin-binding site (Ghiso et al., 1992; Sabo et al., 1995) . The RHD sequence apparently functions as a mimic of the RGD sequence in fibronectin, the matrix ligand of ␣5␤1 (Ruoslahti, 1996a) , because a short peptide containing the RGD sequence inhibits A␤ binding. ␣5␤1 binds only to nonfibrillar A␤, since we did not see any detectable cell adhesion to aggregated fibrillar A␤. Therefore, other receptors presumably mediate cellular interactions with fibrillar A␤, and are responsible for the cytotoxic effects of this form of A␤. The ␣5␤1 integrin is one of the most discriminating of the RGD-directed integrins with regard to its ligand specificity (Ruoslahti, 1996b) . In addition to its main ligand fibronectin, the ␣5␤1 integrin has only been shown to bind to the bacterial protein invasin (Watari et al., 1996) and the insulin-like growth factor binding protein IGFBP-X (Jones et al., 125 I-labeled soluble A␤1-40 was added to the culture media of various IMR-32 (D) or CHO (E) cell lines and incubated for 1 h. After that, the media was removed, the cell layer was washed, and new media was added. The release of radioactivity into the media was monitored over a 72-h period. Experiments in A-E were repeated at least three times, and representative results are shown. Values in A-E represent the mean Ϯ SD; n ϭ 3. 1993). Our results add A␤ among its ligands. The binding site for ␣5␤1 seems to be available only in A␤, not in its precursor protein (APP; B. Bossy, M.L. Matter, and E. Ruoslahti, unpublished results) .
The ␣5␤1 integrin may play a role in the rapid clearance of A␤ that occurs in the normal brain (Ghersi-Egea et al., 1996) . We show that expression of the ␣5␤1 integrin is associated with increased cellular uptake and degradation and decreased matrix deposition of A␤ in cell cultures. Moreover, reversal of this effect with a function-blocking anti-␣5 antibody established a causal link between ␣5␤1 activity and increased clearance of A␤. Although more complex explanations of this effect are possible, the binding of A␤ to ␣5␤1 shown here suggests that A␤ binds to ␣5␤1 at the cell surface, and is subsequently internalized into a cellular compartment where it is degraded. This hypothesis is in agreement with previous results showing that a neuronal cell line internalizes A␤ from culture medium in a manner that is dependent on the NH 2 terminus of A␤ where the RHD sequence resides (Ida et al., 1996) . The lipoprotein Apo J can also reduce the formation of fibrillar A␤ by causing it to be internalized and degraded (Hammad et al., 1997) . Thus, it is likely that more than one mechanism plays a role in the regulation of A␤ accumulation in vivo. Clearly, a transgenic animal expressing the amyloid precursor protein with a mutated RHD sequence would be of great interest in testing the contribution of the RHD sequence and integrin-binding to the metabolism of A␤.
The ␣5␤1 integrin circulates through the endocytic cycle (Bretscher, 1989; Bretscher, 1992) . Inhibiting exocytosis with primaquin causes accumulation of internalized ␣5␤1 in an intracellular pool that returns to the cell surface over time. Recent studies have shown that internalization of fibrillar A␤ promotes accumulation of stable fibrillar A␤ in the late endosome/secondary lysosome compartment, whereas internalization of soluble A␤ leads to degradation of the peptide in the same compartment (Knauer et al., 1992; Koo and Squazzo, 1994; Yang et al., 1995) . This result is in agreement with our data, showing that soluble A␤ is internalized through an ␣5␤1 integrin-mediated pathway, and is at least partially degraded, presumably within endosomes. Thus, clearance of soluble A␤ can be mediated by the ␣5␤1 integrin, presumably through the receptor- mediated endocytosis pathway that normally internalizes this integrin.
␣5␤1 may play a protective role in the brain by suppressing A␤ cytotoxicity. We provide evidence for two separate mechanisms that could be responsible for such a protective effect. First, we show that ␣5␤1-mediated adhe- Ϫ cells IMR-32/c and IMR-32/p showed increased LDH levels, whereas the IMR-32/␣5␤1 clones 4, 15, and 16 maintained LDH levels similar to those seen in the presence of the A␤40-1 control peptide. Values represent the mean Ϯ SD; n ϭ 9. (B) Cell survival on A␤ coated from freshly made solution onto a plastic surface. Cells were seeded onto A␤1-40, fibronectin, and vitronectin coated onto microtiter wells, cultured in serum-free conditions, and examined by DAPI staining after 96 h. The ␣5␤1 transfectants remained viable on A␤1-40 and fibronectin, but not on vitronectin.
sion to nonfibrillar A␤ protects cells from apoptosis in cell culture. Upregulation of Bcl-2 (Zhang et al., 1995) and activation of the MAPK pathway (Wary et al., 1997) may be responsible for this pathway. The second and potentially more important mechanism is suggested by our demonstration that ␣5␤1 suppresses the apoptotic effects of A␤ by reducing production of toxic A␤ matrix.
The ␣5␤1 integrin and ␣v␤1 are present in the adult central nervous system (Grooms et al., 1993) . Immunostaining for ␣5␤1 shows that it is expressed in the vasculature, cortex, and hippocampus of adult rat brain (Bahr et al., 1991; Pagani et al., 1992; Tawil et al., 1994 ; for review see Sargent Jones, 1996) . Moreover, primary hippocampal neurons express ␣5␤1 (Yamazaki et al., 1997) . Soluble A␤1-40 is present in vivo , and is rapidly cleared when injected into normal rats (Ghersi-Egea et al., 1996) . Our results suggest that ␣5␤1 may mediate the clearance of A␤, and that ␣5␤1 may play a significant role in protecting the brain from the A␤-initiated pathology that in its extreme form causes AD.
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